FDA Approves Qternmet XR
FDA Approves Qternmet XR (dapagliflozin, saxagliptin and metformin hydrochloride) for Type 2 Diabetes
3 May 2019 -- The US Food and Drug Administration (FDA) has approved Qternmet XR (dapagliflozin, saxagliptin and metformin h
Vivimed Life Sciences Pvt Ltd Issues Voluntary Nationwide Recall of Losartan Potassium 25 mg, 50 mg and 100 mg Tablets, USP Due to the Detection of Trace Amounts of N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) Impurity
Audience: Consumer, Health Profess
FDA Approves Dengvaxia
FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions
May 01, 2019 -- The U.S. Food and Drug Administration announced today the approval of Dengvaxia, the first vaccine approved for the
Sieta T. de Vries, Ph.D., from the University of Groningen in the Netherlands, and colleagues assessed gender differences in ADRs reported to the national pharmacovigilance center in the Netherlands. To be included, drug-ADR combinations had to be reporte
GSK Receives US Approval of Benlysta for Intravenous Use in Children with Lupus Aged Five Years and Above
London UK, Philadelphia USA April 26, 2019 -- GSK today announced that the US Food and Drug Administration (FDA) has approved, under priority review
FDA Approves Skyrizi
FDA Approves Skyrizi (risankizumab-rzaa) for Moderate to Severe Plaque Psoriasis
NORTH CHICAGO, Ill., April 23, 2019 /PRNewswire/ -- AbbVie today announced that the U.S. Food and Drug Administration (FDA) approved Skyrizi (risanki